The researchers discovered that nanogel technology can carry more than enough gentamicin to be effective—about 36% more gentamicin inside cells compared to standard antibiotic delivery methods.

For instance, a nanogel designed to respond to the acidic environment of a tumor can release its payload selectively at the tumor site, minimizing side effects and improving therapeutic efficacy.